20.09
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
62.84%
13.37
|
8.213 | - | 10.79 | 9.626 |
| Operating Expenses |
0.69%
19.72
|
19.58 | 22.67 | 21.67 | 20.72 |
| Operating Income/Loss |
44.20%
-6.344
|
-11.37 | 19.80 | -10.88 | -11.09 |
| Nonoperating Income/Loss |
8.56%
2.487
|
2.291 | 2.291 | 1.687 | 0.895 |
| Net Income/Loss |
57.52%
-3.857
|
-9.079 | 22.09 | -9.196 | -10.20 |
| Basic Average Shares |
11.56%
18.85
|
16.90 | - | 12.69 | 7.6559 |
| Diluted Average Shares |
11.56%
18.85
|
16.90 | - | 12.69 | 7.6559 |
| Basic Earnings Per Share |
62.96%
-0.20
|
-0.54 | - | -0.72 | -1.33 |
| Diluted Earnings Per Share |
62.96%
-0.20
|
-0.54 | - | -0.72 | -1.33 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):